Skip to main content

12 Result(s)

within J Plumas Remove this filter

and

  1. Article

    Open Access

    HIV triggers immunoregulatory dendritic cells and regulatory T cells through the non-canonical NF-kB pathway

    O Manches, MV Fernandez, J Plumas, L Chaperot, N Bhardwaj in Retrovirology (2012)

    Download PDF (238 KB) View Article

  2. Article

    Open Access

    P16-52. HIV-activated human plasmacytoid DCs induce Tregs through an indoleamine 2,3-dioxygenase-dependent mechanism

    O Manches, D Munn, A Fallahi, J Lifson, L Chaperot, J Plumas, N Bhardwaj in Retrovirology (2009)

    Download PDF (146 KB) View Article

  3. Article

    Erratum: Recurrent genomic aberrations combined with deletions of various tumour suppressor genes may deregulate the G1/S transition in CD4+CD56+ haematodermic neoplasms and contribute to the aggressiveness of the disease

    Correction to: Leukemia (2009) 23, 698–707; doi:10.1038/leukemia.2008.359; published online 22 January 2009 Since the publication of this paper, the authors have noticed that part of Figure 1 has been omitted ...

    F Jardin, M Callanan, D Penther, P Ruminy, X Troussard, J P Kerckaert, M Figeac… in Leukemia (2009)

    Download PDF (897 KB) View Article

  4. No Access

    Article

    Recurrent genomic aberrations combined with deletions of various tumour suppressor genes may deregulate the G1/S transition in CD4+CD56+ haematodermic neoplasms and contribute to the aggressiveness of the disease

    CD4+CD56+ haematodermic neoplasms (HDN) constitute a rare disease characterized by aggressive clinical behaviour and a poor prognosis. Tumour cells from HDN are leukaemic counterparts of plasmacytoid dendritic...

    F Jardin, M Callanan, D Penther, P Ruminy, X Troussard, J P Kerckaert, M Figeac… in Leukemia (2009)

  5. Article

    E2F1 induces apoptosis and sensitizes human lung adenocarcinoma cells to death-receptor-mediated apoptosis through specific downregulation of c-FLIPshort

    E2F1 is a transcription factor that plays a well-documented role during S phase progression and apoptosis. We had previously postulated that the low level of E2F1 in primary lung adenocarcinoma contributes to ...

    C Salon, B Eymin, O Micheau, L Chaperot, J Plumas… in Cell Death & Differentiation (2006)

    Download PDF (517 KB) View Article

  6. No Access

    Article

    Mesenchymal stem cells induce apoptosis of activated T cells

    Mesenchymal stem cells (MSC) have recently been used successfully in humans to control severe graft-versus-host disease. However, the mechanisms involved in their immunomodulatory effects remain a matter of de...

    J Plumas, L Chaperot, M-J Richard, J-P Molens, J-C Bensa, M-C Favrot in Leukemia (2005)

  7. No Access

    Article

    In situ leukemic plasmacytoid dendritic cells pattern of chemokine receptors expression and in vitro migratory response

    Plasmacytoid dendritic cell (PDC) leukemia/lymphoma is a rare neoplasm presenting cutaneous lesions at the time of diagnosis, followed by dissemination to bone marrow, lymph nodes, and other lymphoid and nonly...

    N Bendriss-Vermare, L Chaperot, M Peoc'h, B Vanbervliet, M-C Jacob, F Briere… in Leukemia (2004)

  8. No Access

    Article

    Mechanisms of action of extracorporeal photochemotherapy in the control of GVHD: involvement of dendritic cells

    Despite the fact that extracorporal photochemotherapy (ECP) is now broadly used for the treatment of graft versus host disease or T-cell lymphomas, the mechanisms of its action remain enigmatic. This work prov...

    J Plumas, O Manches, L Chaperot in Leukemia (2003)

  9. No Access

    Article

    Resistance to CD95-mediated apoptosis through constitutive c-FLIP expression in a non-Hodgkin's lymphoma B cell line

    CD95 (Fas/Apo-1) is a transmembrane molecule that induces apoptosis and plays a central role in the regulation of the immune response. The present study describes two new B lymphoid cell lines, B593 and BR97, ...

    M Irisarri, J Plumas, T Bonnefoix, M-C Jacob, C Roucard, M-A Pasquier… in Leukemia (2000)

  10. No Access

    Article

    Differentiation of antigen-presenting cells (dendritic cells and macrophages) for therapeutic application in patients with lymphoma

    The recent clinical trial in lymphoma using tumor antigen-loaded DCs (Hsu et al, Nature Med 1996; 2: 52) demonstrates the efficiency of the use of professional antigen presenting cells (APCs) for taking up, proce...

    L Chaperot, M Chokri, M-C Jacob, P Drillat, F Garban, H Egelhofer, J-P Molens… in Leukemia (2000)

  11. No Access

    Article

    Quantitative analysis detects ubiquitous expression of apoptotic regulators in B cell non-Hodgkin’s lymphomas

    To determine whether the expression levels of Bcl-2 family apoptotic regulators are correlated with the histopathological heterogeneity of B cell non-Hodgkin’s lymphomas (NHL), we quantified their expression i...

    L Xerri, E Devilard, R Bouabdallah, J Hassoun, L Chaperot, F Birg, J Plumas in Leukemia (1999)

  12. No Access

    Article

    Quantification of cellular adhesion molecules on malignant B cells from non-Hodgkin’s lymphoma

    The expression of five cellular adhesion molecules (CAMs), CD54, CD58, CD11a, CD29 and CD49d, was studied in 113 B cell non-Hodgkin’s lymphomas (NHL) and in normal B cells from 12 control lymph nodes. Rather t...

    M-C Jacob, S Agrawal, L Chaperot, C Giroux, R Gressin, F Le Marc’Hadour… in Leukemia (1999)